Hinge Health, Inc. (HNGE) quarterly income statement — complete revenue, gross profit & net income history
Hinge Health, Inc. (HNGE) annual income statement — 3-year revenue, gross profit & net income history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q1'24 |
|---|
| Sales/Revenue | 212.82M | 182.31M | 170.73M | 154.21M | 139.1M | 123.83M | 117.26M | 82.71M |
| Revenue Growth % | 53% | 47.23% | 45.6% | - | - | 49.71% | - | - |
| Cost of Goods Sold | 28.87M | 28.07M | 26.55M | 27.97M | 41.34M | 23.59M | 21.17M | 24.77M |
| COGS % of Revenue | 13.56% | 15.4% | 15.55% | 18.14% | 29.72% | 19.05% | 18.05% | 29.95% |
| Gross Profit | 183.95M | 154.23M | 144.17M | 126.24M | 97.76M | 100.23M | 96.09M | 57.94M |
| Gross Margin % | 86.44% | 84.6% | 84.45% | 81.86% | 70.28% | 80.95% | 81.95% | 70.05% |
| Gross Profit Growth % | 88.16% | 53.87% | 50.04% | - | - | 72.99% | - | - |
| Operating Expenses | 143.51M | 122.16M | 116.92M | 132.33M | 678.43M | 87.1M | 75.18M | 89.36M |
| OpEx % of Revenue | 67.43% | 67.01% | 68.48% | 85.81% | 487.74% | 70.34% | 64.11% | 108.05% |
| Selling, General & Admin | 109.45M | 91.83M | 83.5M | 100.37M | 398.47M | 63.6M | 52.26M | 59.6M |
| SG&A % of Revenue | 51.43% | 50.37% | 48.91% | 65.09% | 286.47% | 51.36% | 44.57% | 72.06% |
| Research & Development | 34.06M | 30.34M | 32.76M | 31.92M | 279.96M | 23.5M | 22.37M | 30.76M |
| R&D % of Revenue | 16% | 16.64% | 19.19% | 20.7% | 201.27% | 18.98% | 19.08% | 37.19% |
| Other Operating Expenses | 0 | 0 | 665K | 40K | 0 | 0 | 551K | -1000K |
| Operating Income | 40.44M | 32.07M | 27.26M | -6.09M | -580.67M | 13.14M | 20.91M | -31.42M |
| Operating Margin % | 19% | 17.59% | 15.96% | -3.95% | -417.45% | 10.61% | 17.83% | -37.99% |
| Operating Income Growth % | 106.96% | 144.13% | 30.35% | - | - | 141.8% | - | - |
| EBITDA | 41.5M | 33.24M | 28.48M | -5.53M | -579.33M | 13.64M | 22.28M | -30.81M |
| EBITDA Margin % | 19.5% | 18.23% | 16.68% | -3.59% | -416.49% | 11.01% | 19% | -37.25% |
| EBITDA Growth % | 107.16% | 143.73% | 27.85% | - | - | 144.27% | - | - |
| D&A (Non-Cash Add-back) | 1.06M | 1.17M | 1.22M | 564K | 1.34M | 503K | 1.37M | 614K |
| EBIT | 44.43M | 32.07M | 28.47M | -6.09M | -580.67M | 13.14M | 21.32M | -31.42M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 3.99M | 3.87M | 4.96M | 4.46M | 4.69M | 109.17M | 5.25M | 5.12M |
| Pretax Income | 44.43M | 35.94M | 32.22M | -1.64M | -575.98M | 122.31M | 26.16M | -26.31M |
| Pretax Margin % | 20.88% | 19.72% | 18.87% | -1.06% | -414.08% | 98.78% | 22.31% | -31.81% |
| Income Tax | 740K | 814K | 122K | 206K | -326K | 998K | -951K | 158K |
| Effective Tax Rate % | 1.67% | 2.26% | 0.38% | -12.58% | 0.06% | 0.82% | -3.63% | -0.6% |
| Net Income | 43.69M | 35.13M | 32.09M | -1.84M | -575.65M | 121.31M | 27.12M | -26.46M |
| Net Margin % | 20.53% | 19.27% | 18.8% | -1.2% | -413.85% | 97.97% | 23.13% | -32% |
| Net Income Growth % | 107.59% | -71.04% | 18.36% | - | - | 558.41% | - | - |
| Net Income (Continuing) | 43.69M | 35.13M | 32.09M | -1.84M | -575.65M | 121.31M | 27.12M | -26.46M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.53 | 0.41 | 0.37 | -0.02 | -7.38 | 1.55 | 0.35 | -0.34 |
| EPS Growth % | 107.18% | -73.55% | 5.71% | - | - | 555.88% | - | - |
| EPS (Basic) | 0.55 | 0.43 | 0.39 | -0.02 | -7.38 | 1.55 | 0.35 | -0.34 |
| Diluted Shares Outstanding | 82.34M | 82.39M | 84.53M | 78.86M | 78.02M | 78.02M | 78.02M | 78.02M |
| Basic Shares Outstanding | 78.8M | 78.62M | 79.52M | 78.86M | 78.02M | 78.02M | 78.02M | 78.02M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |